Valiant Organics

Market Cap: Micro Cap
Industry: Pharmaceuticals & Drugs
ISIN: INE565V01010
NSEID: VALIANTORG
BSEID: 540145

INR

360.00

5.4 (1.52%)

BSENSE

Apr 11, 12:53 PM

BSE+NSE Vol: 48.59 k

{
  "main_header": {
    "sid": 1002678,
    "name": "Valiant Organics",
    "stock_name": "Valiant Organics",
    "full_name": "Valiant Organics Ltd",
    "name_url": "stocks-analysis/valiant-organics",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "360.00",
    "chg": 5.4,
    "chgp": "1.52%",
    "dir": 1,
    "prev_price": "354.60",
    "mcapval": "993.57 Cr",
    "mcap": "Micro Cap",
    "scripcode": 540145,
    "symbol": "VALIANTORG",
    "ind_name": "Pharmaceuticals & Drugs",
    "ind_code": 4,
    "isin": "INE565V01010",
    "curr_date": "Apr 11, 12:53 PM",
    "curr_time": "00:18 AM",
    "bse_nse_vol": "48.59 k",
    "exc_status": "Active",
    "traded_date": "Apr 11, 2025",
    "traded_date_str": "2025 04 11",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://sandbox-www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/valiant-organics-1002678-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Valiant Organics Faces Mixed Technical Trends Amid Market Evaluation Revision",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/valiant-organics-technical-trend-shifts-from-bearish-to-mildly-bearish-amid-stock-price-increase-3-1670994",
        "imagepath": "",
        "date": "2025-04-02 08:08:55",
        "description": "Valiant Organics, a microcap player in the Pharmaceuticals & Drugs industry, has recently undergone an evaluation revision reflecting its current market dynamics. The stock is currently priced at 293.85, showing a notable increase from the previous close of 260.25. Over the past week, Valiant Organics has demonstrated a stock return of 5.59%, contrasting with a decline of 2.55% in the Sensex, indicating a positive short-term performance relative to the broader market.\n\nIn terms of technical indicators, the weekly MACD suggests a mildly bullish sentiment, while the monthly perspective remains bearish. The Relative Strength Index (RSI) shows no significant signals for both weekly and monthly assessments. Bollinger Bands and moving averages indicate a mildly bearish trend on both weekly and monthly scales, reflecting some caution in the stock's performance.\n\nValiant Organics has faced challenges over longer pe..."
      },
      {
        "title": "Valiant Organics Faces Technical Bearish Trends Amid Market Volatility and Declining Performance",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/valiant-organics-technical-trend-shifts-from-mildly-bearish-to-bearish-amid-stock-decline-1619613",
        "imagepath": "",
        "date": "2025-03-27 08:03:30",
        "description": "Valiant Organics, a microcap player in the Pharmaceuticals & Drugs industry, has recently undergone an evaluation revision reflecting its current market dynamics. The stock is currently priced at 266.50, down from a previous close of 278.30, with a notable 52-week high of 455.20 and a low of 225.00. Today's trading saw a high of 289.20 and a low of 262.00, indicating some volatility.\n\nThe technical summary reveals a predominantly bearish sentiment across various indicators. The MACD and KST metrics are bearish on both weekly and monthly scales, while the Bollinger Bands also reflect a bearish trend on the weekly timeframe. The moving averages signal bearish conditions, further supporting the overall technical outlook. Interestingly, the RSI shows no signal on a weekly basis but is bullish on a monthly basis, suggesting mixed signals in momentum.\n\nIn terms of performance, Valiant Organics has faced challenge..."
      },
      {
        "title": "Valiant Organics Faces Mixed Technical Trends Amid Market Evaluation Revision",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/valiant-organics-technical-trend-shifts-from-bearish-to-mildly-bearish-amid-stock-price-increase-1575963",
        "imagepath": "",
        "date": "2025-03-25 08:05:35",
        "description": "Valiant Organics, a microcap player in the Pharmaceuticals & Drugs industry, has recently undergone an evaluation revision reflecting its current market dynamics. The stock is currently priced at 293.10, showing a notable increase from the previous close of 270.95. Over the past year, Valiant Organics has faced challenges, with a return of -29.1%, contrasting sharply with the Sensex's gain of 7.07% during the same period.\n\nIn terms of technical indicators, the weekly MACD suggests a mildly bullish sentiment, while the monthly perspective remains bearish. The Relative Strength Index (RSI) shows no significant signals for both weekly and monthly assessments. Bollinger Bands indicate a mildly bearish trend on both timeframes, and moving averages also reflect a mildly bearish stance on a daily basis. The KST remains bearish on both weekly and monthly evaluations, while the On-Balance Volume (OBV) shows no trend..."
      },
      {
        "title": "Valiant Organics Hits 52-Week Low Amidst Declining Financial Metrics and Market Challenges",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/valiant-organics-hits-new-52-week-low-at-rs-225-amid-declining-performance-1426187",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/3/ValiantOrganics_priceRelatedfactors_685266.png",
        "date": "2025-03-18 09:56:07",
        "description": "Valiant Organics, a microcap in the Pharmaceuticals & Drugs sector, has reached a new 52-week low, reflecting a substantial decline over the past year. Despite some resilience compared to its sector, the company faces challenges, including a significant drop in operating profit and low inventory turnover."
      },
      {
        "title": "Valiant Organics Hits 52-Week Low Amid Declining Financial Metrics and Investor Participation",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/valiant-organics-hits-52-week-low-amid-42-56-year-to-date-decline-2-1426203",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/3/ValiantOrganics_priceRelatedfactors_685260.png",
        "date": "2025-03-18 09:56:06",
        "description": "Valiant Organics, a microcap in the Pharmaceuticals & Drugs sector, has reached a new 52-week low, reflecting a significant decline over the past year. Despite some resilience compared to its sector, the company faces challenges, including declining operating profit and reduced institutional investor participation."
      },
      {
        "title": "Valiant Organics Hits 52-Week Low Amid Declining Profitability and Investor Confidence",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/valiant-organics-hits-52-week-low-amid-significant-stock-decline-and-poor-performance-2-1426021",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/3/ValiantOrganics_priceRelatedfactors_685261.png",
        "date": "2025-03-18 09:56:06",
        "description": "Valiant Organics, a microcap in the Pharmaceuticals & Drugs sector, reached a new 52-week low today, reflecting a significant decline over the past year. Despite recent challenges, the stock showed slight recovery after seven days of losses. Key financial metrics reveal troubling trends, including declining operating profit and low return on capital employed."
      },
      {
        "title": "Valiant Organics Faces Significant Volatility Amidst Declining Financial Performance and Investor Interest",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/valiant-organics-hits-52-week-low-of-rs-225-amid-significant-annual-decline-1426199",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/3/ValiantOrganics_priceRelatedfactors_685263.png",
        "date": "2025-03-18 09:56:05",
        "description": "Valiant Organics, a microcap in the Pharmaceuticals & Drugs sector, hit a new 52-week low today, reflecting a significant annual decline. Despite this, the company outperformed its sector slightly. Financial challenges persist, including a notable drop in operating profit and reduced institutional investor stakes, though it maintains a strong debt management ratio."
      },
      {
        "title": "Valiant Organics Hits 52-Week Low Amidst Declining Profitability and Investor Confidence",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/valiant-organics-hits-52-week-low-of-rs-225-amid-significant-stock-decline-1426210",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/3/ValiantOrganics_priceRelatedfactors_685258.png",
        "date": "2025-03-18 09:56:04",
        "description": "Valiant Organics, a microcap in the Pharmaceuticals & Drugs sector, reached a new 52-week low today, down 42.56% over the past year. Despite a slight recovery after seven days of decline, the stock remains below key moving averages, reflecting ongoing challenges in profitability and market confidence."
      },
      {
        "title": "Valiant Organics Faces Significant Challenges Amidst Broader Market Gains",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/valiant-organics-hits-52-week-low-amid-continued-decline-and-poor-performance-1400780",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/3/ValiantOrganics_priceRelatedfactors_680886.png",
        "date": "2025-03-17 10:12:20",
        "description": "Valiant Organics, a microcap in the Pharmaceuticals & Drugs sector, has hit a new 52-week low amid significant volatility. The company faces challenges with declining operating profits, negative return on capital employed, and reduced institutional investor participation, contributing to its ongoing underperformance against market benchmarks."
      }
    ],
    "total": 38,
    "sid": "1002678",
    "stock_news_url": "https://sandbox-www.marketsmojo.com/news/valiant-organics-1002678"
  },
  "announcements": [
    {
      "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
      "datetime": "05-Apr-2025",
      "details": "Please find our intimation in captioned subject",
      "source": "BSE"
    },
    {
      "caption": "Closure of Trading Window",
      "datetime": "26-Mar-2025",
      "details": "Please find our intimation in captioned subject",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Allotment",
      "datetime": "25-Mar-2025",
      "details": "Please find our intimation in captioned subject",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Valiant Organics Ltd has declared <strong>10%</strong> dividend, ex-date: 10 Feb 23",
          "dt": "2023-02-10",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "",
      "data": [
        {
          "txt": "Valiant Organics Ltd has announced <strong>1:1</strong> bonus issue, ex-date: 24 Dec 20",
          "dt": "2020-12-24",
          "middle_text": "Bonus Alert"
        }
      ]
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Valiant Organics Faces Mixed Technical Trends Amid Market Evaluation Revision

2025-04-02 08:08:55

Valiant Organics, a microcap player in the Pharmaceuticals & Drugs industry, has recently undergone an evaluation revision reflecting its current market dynamics. The stock is currently priced at 293.85, showing a notable increase from the previous close of 260.25. Over the past week, Valiant Organics has demonstrated a stock return of 5.59%, contrasting with a decline of 2.55% in the Sensex, indicating a positive short-term performance relative to the broader market. In terms of technical indicators, the weekly MACD suggests a mildly bullish sentiment, while the monthly perspective remains bearish. The Relative Strength Index (RSI) shows no significant signals for both weekly and monthly assessments. Bollinger Bands and moving averages indicate a mildly bearish trend on both weekly and monthly scales, reflecting some caution in the stock's performance. Valiant Organics has faced challenges over longer pe...

Valiant Organics Faces Technical Bearish Trends Amid Market Volatility and Declining Performance

2025-03-27 08:03:30

Valiant Organics, a microcap player in the Pharmaceuticals & Drugs industry, has recently undergone an evaluation revision reflecting its current market dynamics. The stock is currently priced at 266.50, down from a previous close of 278.30, with a notable 52-week high of 455.20 and a low of 225.00. Today's trading saw a high of 289.20 and a low of 262.00, indicating some volatility. The technical summary reveals a predominantly bearish sentiment across various indicators. The MACD and KST metrics are bearish on both weekly and monthly scales, while the Bollinger Bands also reflect a bearish trend on the weekly timeframe. The moving averages signal bearish conditions, further supporting the overall technical outlook. Interestingly, the RSI shows no signal on a weekly basis but is bullish on a monthly basis, suggesting mixed signals in momentum. In terms of performance, Valiant Organics has faced challenge...

Valiant Organics Faces Mixed Technical Trends Amid Market Evaluation Revision

2025-03-25 08:05:35

Valiant Organics, a microcap player in the Pharmaceuticals & Drugs industry, has recently undergone an evaluation revision reflecting its current market dynamics. The stock is currently priced at 293.10, showing a notable increase from the previous close of 270.95. Over the past year, Valiant Organics has faced challenges, with a return of -29.1%, contrasting sharply with the Sensex's gain of 7.07% during the same period. In terms of technical indicators, the weekly MACD suggests a mildly bullish sentiment, while the monthly perspective remains bearish. The Relative Strength Index (RSI) shows no significant signals for both weekly and monthly assessments. Bollinger Bands indicate a mildly bearish trend on both timeframes, and moving averages also reflect a mildly bearish stance on a daily basis. The KST remains bearish on both weekly and monthly evaluations, while the On-Balance Volume (OBV) shows no trend...

Valiant Organics Hits 52-Week Low Amidst Declining Financial Metrics and Market Challenges

2025-03-18 09:56:07

Valiant Organics, a microcap in the Pharmaceuticals & Drugs sector, has reached a new 52-week low, reflecting a substantial decline over the past year. Despite some resilience compared to its sector, the company faces challenges, including a significant drop in operating profit and low inventory turnover.

Valiant Organics Hits 52-Week Low Amid Declining Financial Metrics and Investor Participation

2025-03-18 09:56:06

Valiant Organics, a microcap in the Pharmaceuticals & Drugs sector, has reached a new 52-week low, reflecting a significant decline over the past year. Despite some resilience compared to its sector, the company faces challenges, including declining operating profit and reduced institutional investor participation.

Valiant Organics Hits 52-Week Low Amid Declining Profitability and Investor Confidence

2025-03-18 09:56:06

Valiant Organics, a microcap in the Pharmaceuticals & Drugs sector, reached a new 52-week low today, reflecting a significant decline over the past year. Despite recent challenges, the stock showed slight recovery after seven days of losses. Key financial metrics reveal troubling trends, including declining operating profit and low return on capital employed.

Valiant Organics Faces Significant Volatility Amidst Declining Financial Performance and Investor Interest

2025-03-18 09:56:05

Valiant Organics, a microcap in the Pharmaceuticals & Drugs sector, hit a new 52-week low today, reflecting a significant annual decline. Despite this, the company outperformed its sector slightly. Financial challenges persist, including a notable drop in operating profit and reduced institutional investor stakes, though it maintains a strong debt management ratio.

Valiant Organics Hits 52-Week Low Amidst Declining Profitability and Investor Confidence

2025-03-18 09:56:04

Valiant Organics, a microcap in the Pharmaceuticals & Drugs sector, reached a new 52-week low today, down 42.56% over the past year. Despite a slight recovery after seven days of decline, the stock remains below key moving averages, reflecting ongoing challenges in profitability and market confidence.

Valiant Organics Faces Significant Challenges Amidst Broader Market Gains

2025-03-17 10:12:20

Valiant Organics, a microcap in the Pharmaceuticals & Drugs sector, has hit a new 52-week low amid significant volatility. The company faces challenges with declining operating profits, negative return on capital employed, and reduced institutional investor participation, contributing to its ongoing underperformance against market benchmarks.